FINWIRES · TerminalLIVE
FINWIRES

Daily Roundup of Key US Economic Data for May 5

By

-- The ISM's services index fell to 53.6 in April from 54.0 in March, with gains in the readings for production and employment and declines for new orders and inventories.

The S&P Global nonmanufacturing index was revised lower in April to 51.0 from the flash 51.3 estimate but was above the 49.8 reading in March.

The RealClearMarkets's sentiment index, the first consumer measure for May, fell to 42.6 from 42.8 in April, with the components mixed. Any reading below 50 indicates more pessimism than optimism.

Job openings declined in March while hiring surged, but separations were also up from the previous month.

New-home sales rose to a 682,000 annual rate in March from a 635,000 rate in February, up 3.3% from the level in March 2025.

The international trade deficit widened to $60.31 billion in March from $57.78 billion in February as imports rose faster than exports.

Redbook reported that US same-store retail sales were up 7.8% year-over-year in the week ended May 2, slightly faster than a 7.7% gain in the prior week due to due to warmer weather and Mother's Day sales.

The Q2 GDP nowcast estimate from the Atlanta Fed is for a 3.7% gain, up from the previous estimate of a 3.5% gain.

Related Articles

Mining & Metals

Earnings Flash (KBL.TO) K-Bro Linen Reports Q1 Revenue $139.1M, Up 52.9% YoY

$KBL.TO
Equities

Occidental Petroleum Q1 Adjusted Earnings Rise, Revenue Falls

Occidental Petroleum (OXY) reported Q1 adjusted earnings late Tuesday of $1.06 per diluted share, up from $0.87 a year earlier.Analysts polled by FactSet expected $0.60.Revenue for the three months ended March 31 was $5.23 billion, down from $5.70 billion a year earlier.Analysts surveyed by FactSet expected $5.44 billion.

$OXY
Mining & Metals

Curaleaf Swings to Q1 Profit As Revenues Beat Expectations

Curaleaf (CURA.TO) reported a swing to a surprise first-quarter profit, boosted by better than expected revenues.The company reported net income from continuing operations of US$70.1 million, or US$0.09 per share, compared with a loss of US$50.1 million, or a loss of US$0.09 per share. Analysts polled by FactSet had forecast a loss of US$0.08 per share.Revenue climbed 6% over the same period, to US$324 million, beating the US$317 million forecast."The macro headwinds that constrained growth over the past three years are now beginning to turn into meaningful tailwinds. Moreover, the historic rescheduling of medical cannabis provides a shift in the trajectory of our business and the industry overall, for which we are well-positioned," said chief executive Boris Jordan. "The investments we've made in the core pillars of our "Built for Growth" strategy are translating directly into tangible performance," he added.Curaleaf shares closed up $0.28, to $4.73 on Tuesday on the Toronto Stock Exchange.

$CURA.TO$HMMJ.TO